SKI Market

A+| A| A-|

Indian Indices

Sensex

78,493.54 504.86
( 0.65%)

Global Indices

Nasdaq

48,584.63 99.90
(0.21%)

Dow Jones

7,060.44 16.49
(0.23%)

Hang Seng

58,837.37 -680.97
(-1.14%)

Nikkei 225

10,588.49 28.91
(0.27%)

Forex

USD-INR

93.31 0.07
(0.07%)

EUR-INR

110.03 0.14
(0.13%)

GBP-INR

126.56 0.24
(0.19%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

AAVAS Financiers Ltd

Industry : Finance - Housing

BSE Code

ISIN Demat

Book Value()

541988

INE216P01012

590.2913

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AAVAS

16.52

10357.1

EPS(TTM)

Face Value()

Div & Yield %

79.07

Back

Aarey Drugs & Pharmaceuticals standalone net profit declines 36.25% in the September 2025 quarter

Nov 14,2025

Net profit of Aarey Drugs & Pharmaceuticals declined 36.25% to Rs 1.02 crore in the quarter ended September 2025 as against Rs 1.60 crore during the previous quarter ended September 2024. Sales declined 19.95% to Rs 84.16 crore in the quarter ended September 2025 as against Rs 105.14 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	84.16	105.14	-20
OPM %	3.14	3.55	-
PBDT	2.17	3.26	-33
PBT	1.48	1.75	-15
NP	1.02	1.60	-36

78,493.54 504.86 ( 0.65%)

48,584.63 99.90 (0.21%)

7,060.44 16.49 (0.23%)

58,837.37 -680.97 (-1.14%)

10,588.49 28.91 (0.27%)

93.31 0.07 (0.07%)

110.03 0.14 (0.13%)

126.56 0.24 (0.19%)

0.59 0.00 (0.06%)